drugset / Trial / NCT00223548

MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application

NCT00223548

Phase 2 Completed 106 enrolled University of Ulm
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine wether Mesna could prevent contrast-induced nephropathy

Timeline

Start
2002-10
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 2-MERCAPTOETHANESULFONIC ACID Small molecule